Announced Wed, 21 May · 17:57 IST

Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve Results for the quarter ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The board of directors of Arunjyoti Bio Ventures Ltd will meet on Thursday, 29 May 2025, at the company's registered office in Madhapur, Hyderabad. The main agenda is to consider and approve the audited financial results for the quarter and full year ended 31 March 2025. Any other business may also be taken up with the chair's permission. The intimation was signed by Whole-Time Director P.B.N. Murthy and filed with BSE under scrip code 530881. No actual financial numbers or outcomes are disclosed in this filing — it is purely a notice of the upcoming meeting.

Likely market impact

This is a routine regulatory filing ahead of the Q4 and FY25 earnings announcement. Investors should look out for the actual audited results, expected to be published on or shortly after 29 May 2025, for any meaningful impact on the stock.